RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Trinity Biotech P/E 2024

Trinity Biotech P/E

-20.22

Trinity Biotech Dividend yield

14.38 %

Ticker

TRIB

ISIN

US8964383066

WKN

A0ET3S

As of May 16, 2024, Trinity Biotech's P/E ratio was -20.22, a -29.82% change from the -28.81 P/E ratio recorded in the previous year.

The Trinity Biotech P/E history

Trinity Biotech Aktienanalyse

What does Trinity Biotech do?

Trinity Biotech PLC is a company specialized in the development, production, and marketing of diagnostic tests for infectious diseases, autoimmune diseases, and cancer. The company was founded in 1992 by Ronan O'Caoimh, an experienced manager in the diagnostics industry. Trinity Biotech has continuously expanded its business and is now recognized as one of the leading companies in the industry worldwide. Its business strategy is based on the development and marketing of diagnostic tests utilizing the latest technology and research. The company has a strong focus on continuous research and development of new products and technologies. Trinity Biotech operates in three main divisions: infectious diseases, autoimmune diseases, and cancer diagnostics. The company offers tests for various infectious diseases such as HIV, hepatitis, and tuberculosis in the infectious diseases division. The autoimmune diseases division develops and produces diagnostic tests for autoimmune diseases such as lupus, rheumatoid arthritis, and Sjögren's syndrome. The cancer diagnostics division offers tests for various types of cancer such as breast cancer, prostate cancer, and colon cancer. Trinity Biotech's key products include the Uni-Gold HIV test, the TrinScreen Hepatitis C test, and the Uni-Gold S. pneumoniae test. These tests are highly accurate and reliable diagnostic tools used by clinics and laboratories worldwide. Trinity Biotech has a global presence with offices in North America, Europe, Asia, and the Middle East. The company is committed to providing its customers with the best possible diagnostic technology and support. Overall, Trinity Biotech is a renowned company in the diagnostics industry focused on developing innovative diagnostic tests for infectious diseases, autoimmune diseases, and cancer. With its strong R&D department, wide range of products, and global presence, Trinity Biotech will continue to play a leading role in the industry. Trinity Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Trinity Biotech's P/E Ratio

The Price to Earnings (P/E) Ratio of Trinity Biotech is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Trinity Biotech's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Trinity Biotech is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Trinity Biotech’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Trinity Biotech Stock

What is the price-to-earnings ratio of Trinity Biotech?

The price-earnings ratio of Trinity Biotech is currently -20.22.

How has the price-earnings ratio of Trinity Biotech changed compared to last year?

The price-to-earnings ratio of Trinity Biotech has increased by -29.82% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Trinity Biotech high compared to other companies?

Yes, the price-to-earnings ratio of Trinity Biotech is high compared to other companies.

How does an increase in the price-earnings ratio of Trinity Biotech affect the company?

An increase in the price-earnings ratio of Trinity Biotech would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Trinity Biotech affect the company?

A decrease in the price-earnings ratio of Trinity Biotech would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Trinity Biotech?

Some factors that influence the price-earnings ratio of Trinity Biotech are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Trinity Biotech pay?

Over the past 12 months, Trinity Biotech paid a dividend of 0.22 USD . This corresponds to a dividend yield of about 14.38 %. For the coming 12 months, Trinity Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Trinity Biotech?

The current dividend yield of Trinity Biotech is 14.38 %.

When does Trinity Biotech pay dividends?

Trinity Biotech pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Trinity Biotech?

Trinity Biotech paid dividends every year for the past 1 years.

What is the dividend of Trinity Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Trinity Biotech located?

Trinity Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Trinity Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Trinity Biotech from 7/1/2015 amounting to 0.22 USD, you needed to have the stock in your portfolio before the ex-date on 6/5/2015.

When did Trinity Biotech pay the last dividend?

The last dividend was paid out on 7/1/2015.

What was the dividend of Trinity Biotech in the year 2023?

In the year 2023, Trinity Biotech distributed 0 USD as dividends.

In which currency does Trinity Biotech pay out the dividend?

The dividends of Trinity Biotech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Trinity Biotech stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Trinity Biotech

Our stock analysis for Trinity Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Trinity Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.